These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17187416)

  • 1. Expanding the applicability of noninvasive fibrosis markers in HIV/HCV co-infected patients.
    Schiavon LL; Filho RJ; Narciso JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Hepatology; 2007 Jan; 45(1):257-8. PubMed ID: 17187416
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice.
    Macías J; González J; Ortega E; Tural C; Cabrero E; Burgos A; Pineda JA;
    HIV Med; 2010 Aug; 11(7):439-47. PubMed ID: 20180868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
    Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH
    J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
    Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
    Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive markers of hepatic fibrosis: are they ready for prime time in the management of HIV/HCV co-infected patients?
    Zeremski M; Talal AH
    J Hepatol; 2005 Jul; 43(1):2-5. PubMed ID: 15922482
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
    Moreno S; García-Samaniego J; Moreno A; Ortega E; Pineda JA; del Romero J; Tural C; von Wichmann MA; Berenguer J; Castro A; Espacio R
    J Viral Hepat; 2009 Apr; 16(4):249-58. PubMed ID: 19215579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.
    Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A
    Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Macías J; Mira J; Gilabert I; Neukam K; Roldán C; Viloria M; Moro A; Pineda JA
    HIV Med; 2011 Jan; 12(1):14-21. PubMed ID: 20497249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index.
    Trang T; Petersen JR; Snyder N
    Clin Chim Acta; 2008 Nov; 397(1-2):51-4. PubMed ID: 18692034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.
    Nunes D; Fleming C; Offner G; Craven D; Fix O; Heeren T; Koziel MJ; Graham C; Tumilty S; Skolnik P; Stuver S; Horsburgh CR; Cotton D
    Am J Gastroenterol; 2010 Jun; 105(6):1346-53. PubMed ID: 20179698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
    Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
    Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: a validation study.
    Resino S; Asensio C; Bellón JM; Carmona R; Miralles P; López JC; Cosín J; Álvarez E; Berenguer J
    J Infect; 2011 Nov; 63(5):402-5. PubMed ID: 21839774
    [No Abstract]   [Full Text] [Related]  

  • 15. The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients.
    Shastry L; Wilson T; Lascher S; Nord JA
    AIDS; 2007 Nov; 21(18):2541-3. PubMed ID: 18025895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
    AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.
    Nunes D; Fleming C; Offner G; O'Brien M; Tumilty S; Fix O; Heeren T; Koziel M; Graham C; Craven DE; Stuver S; Horsburgh CR
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):538-44. PubMed ID: 16284529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fibrosis markers: death by validation or a leap of faith?
    Ratziu V
    J Hepatol; 2010 Aug; 53(2):222-4. PubMed ID: 20546961
    [No Abstract]   [Full Text] [Related]  

  • 20. FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
    Morra R; Lebray P; Ingiliz P; Ngo Y; Munteanu M; Ratziu V; Poynard T
    Hepatology; 2008 Jan; 47(1):353-4; author reply 354-6. PubMed ID: 18161711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.